International Journal of Cardiology

Slides:

Advertisements

Similar presentations

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Advertisements

The “no reflow” phenomenon following acute myocardial infarction: Mechanisms and treatment options Sanjiv Kaul, MD Journal of Cardiology Volume 64, Issue.

Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Diabetes: A Meta-Analysis Stavros Stavrakis, MD The American Journal.

The Epidemic of the 20th Century: Coronary Heart Disease

Congestive heart failure: Treat the disease, not the symptom—Return to normalcy Gerald D. Buckberg, MD The Journal of Thoracic and Cardiovascular Surgery

Tetsuro Tsujimoto, Hiroshi Kajio International Journal of Cardiology

B. E. Backus, A. J. Six, J. C. Kelder, M. A. R. Bosschaert, E. G

Risk of coronary heart disease and risk of stroke in women with polycystic ovary syndrome: A systematic review and meta-analysis Sarah A. Anderson, John.

Comparison of chronic type A aortic dissection with acute type A dissection of short-term and long-term survival rate Qinghua Yuan, Hui Yu, Ujit Karmacharya,

Assessment of γ-GT functions as novel risk factor in patients suffering from angina, myocardial infarction and congestive heart failure Sanghamitra Chakraborty,

Assessment of γ-GT functions as novel risk factor in patients suffering from angina, myocardial infarction and congestive heart failure Sanghamitra Chakraborty,

Introduction The American Journal of Medicine

The Epidemic of the 20th Century: Coronary Heart Disease

The surgical and interventional hybrid era: Experiences from China

Frequency of cancer in patients operated on for acute peripheral arterial thrombosis and the impact on prognosis Chalotte Winther Nicolajsen, MD, Maja.

Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from.

Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without.

The influence of training characteristics on the effect of exercise training in patients with coronary artery disease: Systematic review and meta-regression.

Predictors and prognostic impact of silent coronary artery disease in asymptomatic high- risk patients with diabetes mellitus Michael J. Zellweger, Philip.

The incidence and outcomes of acute coronary syndromes in a central European country: Results of the CZECH-2 registry Petr Tousek, Frantisek Tousek,

Decline in risk of recurrent cardiovascular events in the period 1996 to 2014 partly explained by better treatment of risk factors and less subclinical.

Endurance exercise-induced changes in BNP concentrations in cardiovascular patients versus healthy controls Vincent L. Aengevaeren, Maria T.E. Hopman,

Tetsuro Tsujimoto, Hiroshi Kajio International Journal of Cardiology

Association of neutrophils and future cardiovascular events in patients with peripheral artery disease Markus Haumer, MD, Jasmin Amighi, MD, Markus Exner,

Changing axis deviation, paroxysmal atrial fibrillation and elevation of prostate-specific antigen during acute myocardial infarction Salvatore Patanè,

Long-term results of simultaneous carotid endarterectomy and myocardial revascularization with cardiopulmonary bypass used for both procedures Kazutomo.

Perioperative statin therapy in patients at high risk for cardiovascular morbidity undergoing surgery: a review B.A. de Waal, M.P. Buise, A.A.J. van.

Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease Robert.

The Modification of Diet in Renal Disease 4-calculated glomerular filtration rate is a better prognostic factor of cardiovascular events than classical.

Congestive heart failure: Treat the disease, not the symptom—Return to normalcy Gerald D. Buckberg, MD The Journal of Thoracic and Cardiovascular Surgery

On Statin Treatment to Prevent Sepsis in Dialysis Patients

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

A decade after the Surgical Treatment for Ischemic Heart Failure (STICH) trial: Weaving firm clinical recommendations from lessons learned Robert E.

Long-Term Survival After Coronary Arterial Grafts in Patients With End-Stage Renal Disease Taro Nakatsu, MD, Nobushige Tamura, MD, PhD, Yutaka Sakakibara,

International Journal of Cardiology

Recent Temporal Changes in Atherosclerotic Cardiovascular Diseases in Ontario: Clinical and Health Systems Impact Jack V. Tu, MD, PhD, Anam M. Khan,

Comparison of prescription rates and clinical outcomes in acute coronary syndrome patients who underwent percutaneous coronary intervention using different.

Atrial fibrillation: Improvement in identification and stroke preventive therapy —Data from the UK Clinical Practice Research Datalink, 2000–2012 A.C.E.

Support Your Specialty

Fabio De Giorgio, Vincenzo M. Grassi, Matteo Polacco, Vincenzo L

Amit X. Garg, William F. Clark, R. Brian Haynes, Andrew A. House

Efficacy of a Risk Reduction Program to Improve Cardiovascular Outcomes in Patients With Peripheral Arterial Disease: A Propensity Score-Matched Study

Improving Flexibility and Quality of Life for Your Patients: A Must?

Cardiovascular complications in chronic kidney disease

Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock

International Journal of Cardiology

Pulse pressure for selecting the optimal cardiac strategy in patients with type 2 diabetes and coronary artery disease Tetsuro Tsujimoto, Hiroshi Kajio

International Journal of Cardiology

Comparison of the GRACE, HEART and TIMI score to predict major adverse cardiac events in chest pain patients at the emergency department J.M. Poldervaart,

Long-term survival after vascular surgery: Specific influence of cardiac factors and implications for preoperative evaluation Martin R. Back, MD, Fabian.

High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE.

Preoperative evaluation of patients with, or at risk of, coronary artery disease undergoing non-cardiac surgery P.-G. Chassot, A. Delabays, D.R. Spahn

Reported cardiac phenotypes in hereditary hemorrhagic telangiectasia emphasize burdens from arrhythmias, anemia and its treatments, but suggest reduced.

Weekend versus weekday mortality in ST-segment elevation acute myocardial infarction patients between 1985 and 2008 Sanne M. Snelder, Sjoerd T. Nauta,

Trends in mortality risks among 94,328 patients surviving 30days after a first isolated coronary artery bypass graft procedure from 1987 to 2006: A population-based.

Early and Midterm Results of Off-Pump Coronary Artery Bypass Grafting

Cardiovascular calcification in patients with chronic renal failure: Are we on target with this risk factor? Peter A. Mccullough, Sandeep Soman Kidney.

Normal values for myocardial deformation within the right heart measured by feature- tracking cardiovascular magnetic resonance imaging Boyang Liu, Ahmed.

The role of a defined protocol for cardiac risk assessment in decreasing perioperative myocardial infarction in vascular surgery T.J. Bunt, MD Journal.

Long-term outcome of dialysis patients in the United States with coronary revascularization procedures Charles A. Herzog, M.D., Jennie Z. Ma, Allan J.

Dipyridamole thallium 201 scintigraphy to detect coronary artery disease before abdominal aortic surgery Bruce S. Cutler, M.D., Jeffrey A. Leppo, M.D.

P.K. Spanos, MD, A.D. Bisbos, MD, I.I. Arditis, MD

Thirty years of cardiac transplantation at stanford university

Guy S. Reeder, M.D., Raymond J. Gibbons, M.D. Mayo Clinic Proceedings

Although non-stroke outcomes are more common, stroke risk scores can be used for prediction in patients with atrial fibrillation Finlay A. McAlister,

Increased Rehospitalization Rate After Coronary Bypass Operation for Acute Coronary Syndrome: A Prospective Study in 200 Patients Staffan Bjessmo, MD,

International Journal of Cardiology

Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: A randomized trial Vito A. Mannacio, MD, Domenico Iorio, MD, Vincenzo.

M. N. Vicenzi, T. Meislitzer, B. Heitzinger, M. Halaj, L. A

Magnus Dalén, MD, Torbjörn Ivert, MD, PhD, Martin J

Presentation transcript:

International Journal of Cardiology Incremental prognostic value of coronary and systemic atherosclerosis after myocardial infarction Fredrik Calais, Maja Eriksson Östman, Pär Hedberg, Andreas Rosenblad, Jerzy Leppert, Ole Fröbert International Journal of Cardiology Volume 261, Pages 6-11 (June 2018) DOI: 10.1016/j.ijcard.2018.02.035 Copyright © 2018 The Authors Terms and Conditions

Fig. 1 Flowchart describing inclusion in the study. International Journal of Cardiology 2018 261, 6-11DOI: (10.1016/j.ijcard.2018.02.035) Copyright © 2018 The Authors Terms and Conditions

Fig. 2 Panel A: Cumulative risk of death for myocardial infarction patients relative to extent of coronary artery disease; extensive coronary disease (Sullivan extent score [SES] ≥ 17) or limited coronary disease (SES < 17). Panel B: Cumulative risk for myocardial infarction patients to suffer from the composite endpoint of cardiovascular death or hospitalization for cardiovascular disease relative to extent of coronary artery disease; extensive coronary disease (SES ≥ 17) or limited coronary disease (SES < 17). Panel C: Cumulative risk of death for myocardial infarction patients relative to systemic atherosclerotic disease burden; extensive systemic atherosclerosis (SES ≥ 17 and significant extra-cardiac atherosclerotic disease [ECAD]), moderate systemic atherosclerosis (SES ≥ 17 or significant ECAD) or limited systemic atherosclerosis (SES < 17 and no ECAD). Panel D: Cumulative risk for myocardial infarction patients to suffer from the composite endpoint of cardiovascular death or hospitalization for cardiovascular disease relative to systemic atherosclerotic disease burden; extensive systemic atherosclerosis (SES ≥ 17 and ECAD), moderate systemic atherosclerosis (SES ≥ 17 or significant ECAD) or limited systemic atherosclerosis (SES < 17 and no ECAD). International Journal of Cardiology 2018 261, 6-11DOI: (10.1016/j.ijcard.2018.02.035) Copyright © 2018 The Authors Terms and Conditions